Skip to main content
. 2014 Sep;86(3):306–317. doi: 10.1124/mol.114.093377

TABLE 5.

α7 and α7β2-nAChR antagonist pharmacological parameters

Values are the mean ± S.E.M. of the number of indicated replicates (n=).

Subtype DHβE
MLA
Mecamylamine
α-Cbtx
n= log(IC50/M) nH n= log(IC50/M) nH n= log(IC50 / M) nH n= log(IC50/M) nH
α7 (unlinked) 3 −5.2 ± 0.05 −1.0 ± 0.1 3 −8.7 ± 0.1 −1.6 ± 0.2 3 −5.6 ± 0.2 3 −8.6 ± 0.1 2.4 ± 0.5
α7-α7-α7-α7-α7 3 −5.3 ± 0.07 −0.8 ± 0.1 3 −9.0 ± 0.1 −1.6 ± 0.2 3 −6.0 ± 0.2 3 −8.6 ± 0.1 1.3 ± 0.8
α7-α7-β2-α7-α7 3 −5.4 ± 0.10 −0.6 ± 0.1 3 −8.9 ± 0.1 −1.7 ± 0.1 3 −6.0 ± 0.1 3 −8.6 ± 0.1 1.8 ± 0.5
α7-β2-α7-β2-α7 3 −5.4 ± 0.10 −0.7 ± 0.1 3 −8.8 ± 0.1 −1.8 ± 0.1 3 −6.0 ± 0.2 3 −8.5 ± 0.2 1.5 ± 0.6

Antagonist log IC50 and Hill slope (nH) values were derived by nonlinear least-squares curve fitting of the data shown in Fig. 5 to the Hill model. Pharmacological parameters obtained for each antagonist were statistically indistinguishable between all four groups of oocytes according to analysis with one-way analysis of variance.